A. Kaan et al., Cord blood IgE: its determinants and prediction of development of asthma and other allergic disorders at 12 months, ANN ALLER A, 84(1), 2000, pp. 37-42
Background: The value of cord blood IgE in predicting the development of as
thma and other IgE-mediated allergic diseases is unclear.
Objective: The purpose of this study is twofold: (1) to determine factors a
ffecting cord blood IgE level and (2) to determine whether cord blood IgE p
redicts the development of asthma and other IgE-mediated allergic diseases
in high risk (defined as those with at least one first degree relative with
asthma or 2 first degree relatives with other IgE-mediated allergic diseas
es) infants at 12 months.
Methods: The study utilized cord blood obtained from a group of high risk i
nfants who took part in a randomized controlled trial to assess the effecti
veness of an intervention program in the primary prevention of asthma and o
ther IgE-mediated allergic diseases. Total IgE and cotinine in the cord blo
od were measured. Assessment of the infants was done at 12 months for these
diseases.
Results: Sixty-four (17.8%) infants had detectable total IgE in cord blood
>0.5 kU/L. The proportion of infants with elevated cord blood IgE was signi
ficantly higher among nonwhites, birth during winter months, and those with
a maternal history of asthma. There was no correlation between cord blood
IgE and cord blood cotinine level. Cord blood IgE was found to be a signifi
cant predictor for the development of urticaria due to food allergy but not
for other outcomes.
Conclusion: Both genetic and environmental risk factors play a role in dete
rmining the level of IgE in cord blood. Cord blood IgE was a significant ri
sk factor for the development of urticaria due to food allergy at 12 months
of life. As urticaria due to food allergy is a prodrome for anaphylaxis, m
easurement of IgE in cord blood may be indicated in infants at high risk fo
r developing allergic diseases so that preventive measures can be applied.